Day: July 3, 2024

FDA Approves Treatment for Alzheimer’s Disease

The US Food and Drug Administration (FDA) on Tuesday approved Kisunla (donanemab-azbt) injection, produced by Eli Lilly, for the treatment of Alzheimers disease.

Kisunla is the third amyloid-targeting drug approved by the FDA since 2021, following tw…

Read More ...